tiprankstipranks
Trending News
More News >
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market

AstraZeneca Pharma India Limited (ASTRAZEN) Financial Statements

Compare
11 Followers

AstraZeneca Pharma India Limited Financial Overview

AstraZeneca Pharma India Limited's market cap is currently ₹222.07B. The company's EPS TTM is ₹23.3; its P/E ratio is 191.86; and it has a dividend yield of 0.27%. AstraZeneca Pharma India Limited is scheduled to report earnings on May 30, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 17.16B₹ 12.96B₹ 10.03B₹ 8.06B₹ 8.09B
Gross Profit₹ 7.53B₹ 6.95B₹ 5.78B₹ 4.48B₹ 4.78B
Operating Income₹ 2.14B₹ 1.71B₹ 1.49B₹ 696.50M₹ 1.16B
EBITDA₹ 1.98B₹ 2.36B₹ 1.51B₹ 1.01B₹ 1.48B
Net Income₹ 1.16B₹ 1.62B₹ 992.90M₹ 616.00M₹ 933.00M
Balance Sheet
Cash & Short-Term Investments₹ 5.53B₹ 5.06B₹ 5.11B₹ 4.48B₹ 3.52B
Total Assets₹ 15.18B₹ 10.78B₹ 9.85B₹ 8.57B₹ 7.75B
Total Debt₹ 357.30M₹ 45.90M₹ 72.14M₹ 86.30M₹ 121.40M
Net Debt₹ -5.00B₹ -5.01B₹ -4.93B₹ -4.40B₹ -3.40B
Total Liabilities₹ 7.48B₹ 3.66B₹ 3.96B₹ 3.45B₹ 3.19B
Stockholders' Equity₹ 7.70B₹ 7.12B₹ 5.89B₹ 5.11B₹ 4.56B
Cash Flow
Free Cash Flow₹ 636.10M₹ 171.10M₹ 497.70M₹ 911.80M₹ 970.70M
Operating Cash Flow₹ 653.60M₹ 278.70M₹ 582.90M₹ 1.01B₹ 1.05B
Investing Cash Flow₹ 308.00M₹ 217.40M₹ 181.10M₹ 47.40M₹ 1.73B
Financing Cash Flow₹ -655.90M₹ -443.80M₹ -244.80M₹ -94.60M₹ -89.70M
Currency in INR

AstraZeneca Pharma India Limited Earnings and Revenue History

AstraZeneca Pharma India Limited Debt to Assets

AstraZeneca Pharma India Limited Cash Flow

AstraZeneca Pharma India Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis